Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Ann C Collier

Datos Biográficos

ID7729987
NOMBREAnn C Collier
NOMBRESAnn C
APELLIDOCollier
FIRMACOLLIER A C
AFILIACIONESUniversity of Washington
ORCID0000-0001-5673-0422
VERIFICADOSí
TOTAL DE OBRAS9
TOTAL DE CITAS1
TOTAL COMO AUTOR9
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN1986
AÑO MÁS RECIENTE DE PUBLICACIÓN2021
ÍNDICE H1
  • Poor quality of life and incomplete self-reported adherence predict second-line ART virological failure in resource-limited settings

    Tatiany Soares Torres, Lincoln J Harrison et al.•ARTICLE•AIDS Care•2021

    We evaluated health-related quality of life (QoL) and self-reported incomplete adherence as predictors of early second-line antiretroviral (ART) virological failure (VF). ACTG A5273 study participants completed the ACTG SF-21 measure which has 8 QoL domains. We used exact logistic regression to assess the association of QoL at baseline and week 4 with early VF adjusted for self-reported adherence. Of 500 individuals (51% women, median age 39 year…

  • Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV

    Open Access•Rowan Saloner, Judith D Lobo et al.•ARTICLE•AIDS and Behavior•2021

    Despite the neurocognitive risks of aging with HIV, initial cross-sectional data suggest a subpopulation of older people with HIV (PWH) possess youthful neurocognition (NC) characteristic of SuperAgers (SA). Here we characterize longitudinal NC trajectories of older PWH and their convergent validity with baseline SA status, per established SuperAging criteria in PWH, and baseline biopsychosocial factors. Growth mixture modeling (GMM) identified l…

  • A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S

    Open Access•Jane M Simoni, Kenneth Tapia et al.•ARTICLE•AIDS and Behavior•2019

  • Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings

    Tatiany Soares Torres, Thiago S Torres et al.•ARTICLE•AIDS Care•2018

    We evaluated health-related quality of life (QoL) in HIV infection participants with virologic failure (VF) on first-line antiretroviral therapy (ART) in 9 resource-limited settings (RLS). ACTG SF-21 was completed by 512 participants at A5273 study entry; 8 domains assessed: general health perceptions (GHP), physical functioning (PF), role functioning (RF), social functioning (SF), cognitive functioning (CF), pain (P), mental health (MH), and ene…

  • Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV

    Open Access•Doyle E Patton, Steven Paul Wood et al.•ARTICLE•AIDS and Behavior•2012

  • HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy

    Open Access•for the CHARTER and HNRC Groups, Robert K Heaton et al.•ARTICLE•Journal of NeuroVirology•2011

    Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders (HAND) continue to be reported. Because large HIV-infected (HIV+) and uninfected (HIV-) groups have not been studied with similar methods in the pre-CART and CART eras, it is unclear whether CART has changed the prevalence, nature, and clinical correlates of HAND. We used compa…

  • HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

    Open Access•Robert K Heaton, David B Clifford et al.•ARTICLE•Neurology•2010

    OBJECTIVES: This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse sample of infected individuals in the era of combination antiretroviral therapy (CART). METHODS: A total of 1,555 HIV-infected adults were recruited from 6 university clinics across the United States, with minimal exclusions. We used standardized neuromedical, psychiatr…

  • Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

    Mari M Kitahata, Stephen J Gange et al.•ARTICLE•New England Journal of Medicine•2009

    BACKGROUND: The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain. METHODS: We conducted two parallel analyses involving a total of 17,517 asymptomatic patients with HIV infection in the United States and Canada who received medical care during the period from 1996 through 2005. None of the patients had undergone previous antiretroviral therapy. In ea…

  • Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle

    Ann C Collier, Robert C Barnes et al.•ARTICLE•American Journal of Public Health•1986•Citada por: 1•Referencias: 13

    The prevalence of antibody to LAV/HTLV-III among homosexual men attending a community clinic and a sexually transmitted disease clinic in Seattle, Washington in early 1985 was 42 per cent and 32 per cent, respectively. Seropositivity was apparently not related to age or number of sexual partners. The high prevalence of LAV/HTLV-III seropositivity in an area where overt AIDS (acquired immune deficiency syndrome) is still relatively uncommon sugges…

  • Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle

    Ann C Collier, Robert C Barnes et al.•ARTICLE•American Journal of Public Health•1986•Citada por: 1•Referencias: 13

    The prevalence of antibody to LAV/HTLV-III among homosexual men attending a community clinic and a sexually transmitted disease clinic in Seattle, Washington in early 1985 was 42 per cent and 32 per cent, respectively. Seropositivity was apparently not related to age or number of sexual partners. The high prevalence of LAV/HTLV-III seropositivity in an area where overt AIDS (acquired immune deficiency syndrome) is still relatively uncommon sugges…

  • Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle

    Ann C Collier, Robert C Barnes et al.•ARTICLE•American Journal of Public Health•1986•Citada por: 1•Referencias: 13

    The prevalence of antibody to LAV/HTLV-III among homosexual men attending a community clinic and a sexually transmitted disease clinic in Seattle, Washington in early 1985 was 42 per cent and 32 per cent, respectively. Seropositivity was apparently not related to age or number of sexual partners. The high prevalence of LAV/HTLV-III seropositivity in an area where overt AIDS (acquired immune deficiency syndrome) is still relatively uncommon sugges…

  • Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

    Mari M Kitahata, Stephen J Gange et al.•ARTICLE•New England Journal of Medicine•2009

    BACKGROUND: The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain. METHODS: We conducted two parallel analyses involving a total of 17,517 asymptomatic patients with HIV infection in the United States and Canada who received medical care during the period from 1996 through 2005. None of the patients had undergone previous antiretroviral therapy. In ea…

  • HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

    Open Access•Robert K Heaton, David B Clifford et al.•ARTICLE•Neurology•2010

    OBJECTIVES: This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse sample of infected individuals in the era of combination antiretroviral therapy (CART). METHODS: A total of 1,555 HIV-infected adults were recruited from 6 university clinics across the United States, with minimal exclusions. We used standardized neuromedical, psychiatr…

  • HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy

    Open Access•for the CHARTER and HNRC Groups, Robert K Heaton et al.•ARTICLE•Journal of NeuroVirology•2011

    Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders (HAND) continue to be reported. Because large HIV-infected (HIV+) and uninfected (HIV-) groups have not been studied with similar methods in the pre-CART and CART eras, it is unclear whether CART has changed the prevalence, nature, and clinical correlates of HAND. We used compa…

  • Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV

    Open Access•Doyle E Patton, Steven Paul Wood et al.•ARTICLE•AIDS and Behavior•2012

  • Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings

    Tatiany Soares Torres, Thiago S Torres et al.•ARTICLE•AIDS Care•2018

    We evaluated health-related quality of life (QoL) in HIV infection participants with virologic failure (VF) on first-line antiretroviral therapy (ART) in 9 resource-limited settings (RLS). ACTG SF-21 was completed by 512 participants at A5273 study entry; 8 domains assessed: general health perceptions (GHP), physical functioning (PF), role functioning (RF), social functioning (SF), cognitive functioning (CF), pain (P), mental health (MH), and ene…

  • A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S

    Open Access•Jane M Simoni, Kenneth Tapia et al.•ARTICLE•AIDS and Behavior•2019

  • Poor quality of life and incomplete self-reported adherence predict second-line ART virological failure in resource-limited settings

    Tatiany Soares Torres, Lincoln J Harrison et al.•ARTICLE•AIDS Care•2021

    We evaluated health-related quality of life (QoL) and self-reported incomplete adherence as predictors of early second-line antiretroviral (ART) virological failure (VF). ACTG A5273 study participants completed the ACTG SF-21 measure which has 8 QoL domains. We used exact logistic regression to assess the association of QoL at baseline and week 4 with early VF adjusted for self-reported adherence. Of 500 individuals (51% women, median age 39 year…

  • Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV

    Open Access•Rowan Saloner, Judith D Lobo et al.•ARTICLE•AIDS and Behavior•2021

    Despite the neurocognitive risks of aging with HIV, initial cross-sectional data suggest a subpopulation of older people with HIV (PWH) possess youthful neurocognition (NC) characteristic of SuperAgers (SA). Here we characterize longitudinal NC trajectories of older PWH and their convergent validity with baseline SA status, per established SuperAging criteria in PWH, and baseline biopsychosocial factors. Growth mixture modeling (GMM) identified l…

Medicine (9 obras) · HIV Research and Treatment (8 obras) · HIV/AIDS Research and Interventions (7 obras) · Psychiatry (5 obras) · Antiretroviral therapy (4 obras) · Cognition (4 obras) · Disease (4 obras) · Internal Medicine (4 obras) · Internal Medicine (4 obras) · Viral load (4 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae